14 August 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

14 August 2017 | n=33

  1. Komninakis S, Mota ML, Hunter JR, Diaz RS, et al.
    Late Presentation HIV/AIDS Are Still a Challenge in Brazil and Worldwide.
    AIDS Res Hum Retroviruses 2017.

  2. Dow DE, Schimana W, Nyombi BM, Mmbaga BT, et al.
    HIV Resistance with Correlation to PMTCT Regimen in HIV-Infected Infants in Northern Tanzania.
    AIDS Res Hum Retroviruses 2017.

  3. Flynn J, Ellenberg P, Duncan R, Ellett A, et al.
    Analysis of clinical HIV-1 strains with resistance to maraviroc reveals strain-specific resistance mutations, variable degrees of resistance, and minimal cross-resistance to other CCR5 antagonists.
    AIDS Res Hum Retroviruses 2017.

  4. Wang C, Wang Y, Kong D, Xin R, et al.
    Characterization of a Novel HIV-1 Second-Generation Recombinant Form in Men Who Have Sex with Men in Beijing, China.
    AIDS Res Hum Retroviruses 2017.

  5. Murphy RA, Court R, Maartens G, Sunpath H, et al.
    Second-line antiretroviral therapy in sub-Saharan Africa: It's time to mind the gaps.
    AIDS Res Hum Retroviruses 2017.

  6. Veazey R, Ling B.
    Comparative susceptibility of rhesus macaques of Indian and Chinese origin to vaginal SHIV transmission as models for HIV prevention research.
    AIDS Res Hum Retroviruses 2017.

  7. Smibert OC, Trubiano J, Cross GB, Hoy J, et al.
    Mycobacterium avium Complex infection and Immune Reconstitution Inflammatory Syndrome remain a challenge in the era of effective Antiretroviral Therapy.
    AIDS Res Hum Retroviruses 2017.

  8. Crepaz N, Tang T, Marks G, Hall HI, et al.
    Viral Suppression Patterns Among Persons in the United States With Diagnosed HIV Infection in 2014.
    Ann Intern Med 2017.

  9. .
    Distribution of Behavioral Patterns Before Infection Among San Francisco Men Who Have Sex With Men Newly Infected With HIV in 2014: Erratum.
    J Acquir Immune Defic Syndr 2017;76:e33.

  10. Gonzalez-Serna A, Ajaykumar A, Gadawski I, Munoz-Fernandez MA, et al.
    Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion.
    J Acquir Immune Defic Syndr 2017;76:e29-e32.

  11. Drobeniuc AM, Spaulding A.
    Censoring of HIV Viremia Data of Reincarcerated Individuals: A Response to Wohl et al.
    J Acquir Immune Defic Syndr 2017;76:e22-e23.

  12. Chau KH, Scherzer R, Grunfeld C, Hsue PY, et al.
    CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation.
    J Acquir Immune Defic Syndr 2017;76:90-97.

  13. Monroe AK, Fleishman JA, Voss CC, Keruly JC, et al.
    Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical Data.
    J Acquir Immune Defic Syndr 2017;76:82-89.

  14. LaCourse SM, Deya RW, Graham SM, Masese LN, et al.
    Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya.
    J Acquir Immune Defic Syndr 2017;76:74-81.

  15. Yuen T, Brouillette MJ, Fellows LK, Ellis RJ, et al.
    Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection.
    J Acquir Immune Defic Syndr 2017;76:48-54.

  16. Ngandu NK, Carlson JM, Chopera DR, Ndabambi N, et al.
    Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide.
    J Acquir Immune Defic Syndr 2017;76:43-47.

  17. Jacobson DL, Stephensen CB, Miller TL, Patel K, et al.
    Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected Children.
    J Acquir Immune Defic Syndr 2017;76:33-42.

  18. Dombrowski JC, Dorabjee J, Strathdee SA.
    Editorial: Atrocity in the Philippines: How Rodrigo Duterte's War on Drug Users May Exacerbate the Burgeoning HIV Epidemic.
    J Acquir Immune Defic Syndr 2017;76:23-25.

  19. Ransome Y, Dean LT, Crawford ND, Metzger DS, et al.
    How Do Social Capital and HIV/AIDS Outcomes Geographically Cluster and Which Sociocontextual Mechanisms Predict Differences Across Clusters?
    J Acquir Immune Defic Syndr 2017;76:13-22.

  20. Strain JF, Burdo TH, Song SK, Sun P, et al.
    Diffusion Basis Spectral Imaging Detects Ongoing Brain Inflammation in Virologically Well Controlled HIV+ Patients.
    J Acquir Immune Defic Syndr 2017.

  21. Pachankis JE, Hatzenbuehler ML, Berg RC, Fernandez-Davila P, et al.
    Anti-LGBT and Anti-Immigrant Structural Stigma: An Intersectional Analysis of Sexual Minority Men's HIV Risk When Migrating to or Within Europe.
    J Acquir Immune Defic Syndr 2017.

  22. Sugar NR, Schilling KA, Kim S, Ahmed A, et al.
    Integrating Household Water Treatment, Hand Washing, and Insecticide-Treated Bed Nets into Pediatric HIV Care in Mombasa, Kenya: Impact on Diarrhea and Malaria Risk.
    J Acquir Immune Defic Syndr 2017.

  23. Yang T, Chen Q, Li D, Wang T, et al.
    High prevalence of syphilis, HBV and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital.
    J Med Virol 2017.

  24. Jose-Abrego A, Panduro A, Fierro NA, Roman S, et al.
    High prevalence of HBV infection, detection of subgenotypes F1b, A2 and D4 and differential risk factors among Mexican risk populations with low socioeconomic status.
    J Med Virol 2017.

  25. Chaillon A, Nakazawa M, Wertheim JO, Little SJ, et al.
    No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.
    J Virol 2017.

  26. Akiyama H, Ramirez NP, Gibson G, Kline C, et al.
    Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of IFN-alpha.
    J Virol 2017.

  27. Han Q, Williams WB, Saunders KO, Seaton KE, et al.
    HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques.
    J Virol 2017.

  28. Pitoiset F, Vazquez T, Levacher B, Nehar-Belaid D, et al.
    Retrovirus-based Virus-Like Particle Immunogenicity and its Modulation by Toll-Like Receptor Activation.
    J Virol 2017.

  29. Bardhi A, Wu Y, Chen W, Zhu Z, et al.
    Potent In Vivo NK Cell-mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-bispecific and Hexavalent Broadly Neutralizing Fusion Protein.
    J Virol 2017.

  30. Karim SSA, Karim QA, Abimiku A, Bekker LG, et al.
    Closing the NIH Fogarty Center threatens US and global health.
    Lancet 2017;390:451.

  31. Kumar P, Suri D, Vignesh P, Attri SV, et al.
    Metabolic Abnormalities and Clinical Lipodystrophy in Children with Human Immunodeficiency Virus Infection: A Report from A Tertiary-Care-Center in India.
    Pediatr Infect Dis J 2017.

  32. Bonnet M, Nansumba M, Bastard M, Orikiriza P, et al.
    Outcome of Children with Presumptive Tuberculosis in Mbarara, Rural Uganda.
    Pediatr Infect Dis J 2017.

  33. Elangasinghe MA.
    Considering syphilis and HIV in differential diagnoses.
    BMJ 2017;358:j3633.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

16 July 2018

09 July 2018

02 July 2018

25 June 2018

18 June 2018

14 August 2017

Multidisciplinary Journal Club

  1. Zenner D, Beer N, Harris RJ, Lipman MC, et al.
    Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
    Ann Intern Med. 2017 Aug 1. doi: 10.7326/M17-0609.

  2. Bress AP, Kramer H, Khatib R, Beddhu S, et al.
    Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nut
    Circulation. 2017;135:1617-1628.

  3. Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, et al.
    Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.
    Lancet. 2017 Jul 26. pii: S0140-6736(17)31613.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016